Hidradenitis Suppurativa and Use of CO2 Laser for Treatment

Feb 15, 2018 3:00pm ‐ Feb 15, 2018 4:00pm


A Hidradenitis Suppurativa (HS) patient's initial experience usually happens outside dermatology causing a delay in diagnosis by an average of seven years. During the seven year delay many of our patients experience depression, embarrassment and progression of the disease due to misdiagnosis leading to poor inadequate care. HS is a chronic, non-contagious, painful and debilitating inflammatory skin disease affecting 1-4% of the global population. Most commonly found in skin folds, producing deep-seated follicular papules and pustules. Our goal is to promote HS awareness through education and patient support. Creating timely diagnosis we can improve patient care and patient quality of life.

Learning Outcomes:

  • Identify the manifestations, diagnosis, comorbidities and stages of Hidradenitis Suppurativa (HS).
  • Describe the 1st, 2nd and 3rd line treatment options to manage HS, explaining the pharmacokinetics, dosing, potential adverse reactions and method of delivery for each.
  • Educate patient on the use of CO2 Laser surgery as a treatment including pre and post op care.


  • Sherri Minchella, BBA, ADN, RN, Nurse Manager, Henry Ford Health System
  • Nicole VanHaaren, BSN, BBA, RN, Nursing Supervisor Dermatology, Henry Ford Health System

You must be logged in and own this session in order to post comments.